deltatrials
Active Not Recruiting PHASE3 INTERVENTIONAL 2-arm NCT04564157

New Adjuvant Trial of Chemotherapy vs Chemo-immunotherapy (NADIM-ADJUVANT)

A Phase III Clinical Trial of Adjuvant Chemotherapy vs Chemoimmunotherapy for Stage IB-IIIA Completely Resected Non-small Cell Lung Cancer (NSCLC) Patients.

Sponsor: Fundación GECP

Conditions Adjuvant Chemotherapy Non-Small Cell Lung Cancer
Interventions Carboplatin Nivolumab Paclitaxel
Updated 14 times since 2020 Last updated: Apr 8, 2025 Started: Jan 13, 2021 Primary completion: Apr 1, 2030 Completion: Apr 1, 2031
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04564157, this PHASE3 trial focuses on Adjuvant Chemotherapy and Non-Small Cell Lung Cancer and remains ongoing. Sponsored by Fundación GECP, it has been updated 14 times since 2021, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Oct 2020 – ~Nov 2020 · 31 days · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Dec 2021 · 9 months · monthly snapshot~Dec 2021 – ~Jun 2022 · 6 months · monthly snapshot~Jun 2022 – ~Jul 2022 · 30 days · monthly snapshot~Jul 2022 – ~Jul 2023 · 12 months · monthly snapshot~Jul 2023 – ~Feb 2024 · 7 months · monthly snapshot~Feb 2024 – ~Jul 2024 · 5 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshot~Feb 2025 – ~May 2025 · 3 months · monthly snapshot~May 2025 – ~Sep 2025 · 4 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2025 — Present [monthly]

    Active Not Recruiting PHASE3

  2. May 2025 — Sep 2025 [monthly]

    Active Not Recruiting PHASE3

  3. Feb 2025 — May 2025 [monthly]

    Active Not Recruiting PHASE3

  4. Sep 2024 — Feb 2025 [monthly]

    Active Not Recruiting PHASE3

  5. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE3

▶ Show 9 earlier versions

  1. Feb 2024 — Jul 2024 [monthly]

    Active Not Recruiting PHASE3

    Status: Recruiting → Active Not Recruiting

  2. Jul 2023 — Feb 2024 [monthly]

    Recruiting PHASE3

  3. Jul 2022 — Jul 2023 [monthly]

    Recruiting PHASE3

  4. Jun 2022 — Jul 2022 [monthly]

    Recruiting PHASE3

  5. Dec 2021 — Jun 2022 [monthly]

    Recruiting PHASE3

  6. Mar 2021 — Dec 2021 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  7. Jan 2021 — Mar 2021 [monthly]

    Not Yet Recruiting PHASE3

  8. Nov 2020 — Jan 2021 [monthly]

    Not Yet Recruiting PHASE3

  9. Oct 2020 — Nov 2020 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Fundación GECP
Data source: Fundación GECP

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

A Coruña, Spain , Alicante, Spain , Badalona, Spain , Barakaldo, Spain , Barcelona, Spain , Bilbao, Spain , Cáceres, Spain , El Palmar, Spain , Girona, Spain , Jaén, Spain and 10 more locations